Thalassemia major is an inherited blood disorder in which the body cannot produce enough healthy hemoglobin. Children with severe thalassemia may require regular blood transfusions throughout life, along with medicines to control iron overload.

The good news is that hematopoietic stem cell transplantation (bone marrow transplant/BMT) can potentially cure thalassemia in appropriately selected patients.

What is Thalassemia Major?

Thalassemia major, commonly referring to transfusion-dependent β-thalassemia, is a genetic condition. Because the child’s bone marrow cannot produce adequate normal hemoglobin, regular red blood cell transfusions are needed to maintain hemoglobin levels and normal growth.

Over time, repeated transfusions can cause iron overload, which may affect the heart, liver, endocrine organs and other tissues.

Can Thalassemia Be Cured?

Yes. Allogeneic hematopoietic stem cell transplantation is currently the established potentially curative treatment for transfusion-dependent thalassemia.

The best results are generally obtained when transplantation is performed before significant iron-related or other organ damage develops.

Who Can Undergo a Bone Marrow Transplant?

Important factors considered before transplant include:

• Age of the child
• Overall health
• Liver and cardiac status
• Degree of iron overload
• Previous transfusion history
• Presence of complications
• Availability of a suitable donor
• Thalassemia risk category
• Family and psychosocial considerations

A detailed evaluation is necessary before deciding whether transplantation is appropriate.

Who Can Be a Donor?

The ideal donor is usually a fully HLA-matched sibling.

If a matched sibling is not available, transplantation may sometimes be considered using other donor options, including:

• Matched unrelated donor
• Haploidentical family donor
• Other alternative donor approaches

The choice depends on the child’s individual circumstances and the expertise of the transplant centre.

What Happens During a Bone Marrow Transplant?

The transplant process generally includes:

1. Pre-transplant evaluation
   The child undergoes detailed blood tests, infection screening, cardiac and liver assessment, imaging and other investigations.
2. Conditioning therapy
   Medicines are given to suppress the existing bone marrow and immune system and prepare the body to receive donor stem cells.
3. Stem cell infusion
   Healthy blood-forming stem cells from the donor are infused through a central venous catheter. This is similar to a blood transfusion.
4. Engraftment
   The donor stem cells begin producing healthy blood cells. This process usually takes several weeks.
5. Post-transplant monitoring
   The child is closely monitored for infections, graft-versus-host disease, graft failure and other complications.

What Are the Benefits?

Successful transplantation can allow the child to:

• Become independent of regular blood transfusions
• Avoid progressive transfusional iron accumulation
• Reduce the risk of future iron-related complications
• Achieve normal or near-normal hematopoiesis

However, transplantation is a major procedure and is not completely risk-free.

What Are the Risks?

Potential complications include:

• Infections
• Graft-versus-host disease
• Graft failure
• Liver complications
• Mucositis
• Infertility or endocrine complications
• Treatment-related organ toxicity
• Transplant-related mortality

The individual risk varies significantly depending on the child’s age, iron burden, organ function, donor type and transplant protocol.

Why Early Referral Is Important

One of the most important messages for parents is:

Do not wait until severe complications develop before discussing transplant.

Children with transfusion-dependent thalassemia should be evaluated early by a Pediatric Hematology and Bone Marrow Transplant specialist so that treatment options can be discussed at the appropriate time.

What About Iron Chelation Before Transplant?

Iron overload should be assessed and managed carefully before transplantation. Appropriate chelation therapy can help reduce iron burden and may improve the child’s overall condition before transplant.

After transplantation, iron stores may still require monitoring and, in some children, additional treatment.

Frequently Asked Questions

Is bone marrow transplant a permanent cure for thalassemia?

Successful transplantation can provide long-term, transfusion-independent normal blood production and is considered a potentially curative treatment.

Is BMT possible if there is no matched sibling?

Yes. Other donor options may be considered in selected patients, including matched unrelated and haploidentical donors.

What is the best age for transplant?

There is no single age that is best for every child. Earlier transplantation, before significant iron-related organ damage, generally offers important advantages, but the decision must be individualized.

Does every child with thalassemia need a transplant?

No. Transplantation is not automatically required for every patient. The decision depends on disease severity, donor availability, age, iron overload, organ function, transplant risk and family preferences.

⸻

A message for parents

Thalassemia major is a serious disease, but parents should know that curative treatment is possible for appropriately selected children.

If your child has transfusion-dependent thalassemia, discuss bone marrow transplantation and other available treatment options with a pediatric hematology/BMT specialist rather than waiting for complications to develop.

Early evaluation can make a major difference.